<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0038826" disease_type="Disease or Syndrome" abbrv="">Superinfection</z:e> of Raji cells with Epstein-Barr virus (EBV) or chemical induction of HR-1 cells with 12-O-<z:chebi fb="0" ids="25456">tetradecanoyl</z:chebi>-<z:chebi fb="0" ids="45127">phorbol-13-acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) results in the induction of a deoxyuridine <z:chebi fb="0" ids="15266,18036">triphosphate</z:chebi> nucleotidohydrolase (dUTPase) which is not observed in mock-treated cells or <z:chebi fb="6" ids="15702,53394">TPA</z:chebi>-treated EBV genome-negative BJAB cells </plain></SENT>
<SENT sid="1" pm="."><plain>The EBV-induced dUTPase could be distinguished from the host dUTPase based upon differences in their migration in <z:chebi fb="0" ids="53656">polyacrylamide</z:chebi> gels and sensitivity to the 5-mercurithioguanosine derivitive of <z:chebi fb="0" ids="17625">dUTP</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The expression of the EBV-specified dUTPase is prevented by <z:chebi fb="0" ids="15732">phosphonoacetic acid</z:chebi> indicating that its expression is dependent upon EBV-DNA replication </plain></SENT>
</text></document>